4th May, 2016, New Jersey, USA: Freyr makes it to the fore again. Silicon India, a trusted online and print community, has listed Freyr as one of the “20 most promising Pharma & Life Sciences Solution Providers – 2016.”
Acknowledging the strategic role of external service providers in a trillion dollar worth global pharmaceutical industry, Silicon India has brought out a list of the 20 most promising Pharma & Life Sciences Solutions providers for the year 2016. Freyr has been awarded this coveted spot for its best practices in the Global Regulatory Solutions and Services arena.
“This feature re-enforces Fryer’s commitment to addressing the complex challenges across the wide and diverse Regulatory segments such as Regulatory Affairs and Operations, Submissions and Publishing, Regulatory Intelligence, Labeling and Artwork, Authority Directives, Regulatory Strategy and Business Consulting and Regulatory Information Management. Freyr has been successfully providing these hi-end, next-generation Regulatory Solutions and Services to many of the Top 10 Global Pharma, Top 5 Biotech, Top 20 Generics, Top 20 Consumer Healthcare and Several Small-Medium global Bio-Pharma companies”, said Rajiv Rangan, Co-Ceo, Freyr.
Freyr exclusively focuses on the entire Regulatory value-chain of Bio-Pharma (Innovators / Generics), Consumer Healthcare and Medical Device companies and is one of the few global companies to have pioneered specialized Centers of Excellence (CoEs) supported by rapidly growing teams of 400+ Regulatory Professionals. For more information, visit http://www.freyrsolutions.com/.
For more details on this release, please contact:
Sana W Patel
+91 - 9100 941 932